http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 13 Oct 2026 07:32:43 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Zimmer+Biomet+and+Think+Surgical+extend+robotic+distribution+deal/27177112.html <p>Zimmer Biomet Holdings, Inc. (NYSE: ZBH) and Think Surgical, Inc. have agreed to a multi-year extension of their Limited Exclusive Distribution and Supply Agreement, the companies announced Oct. 13, 2026.</p><p>Under the extended agreement, Zimmer Biomet will continue to distribute an exclusive version of Think Surgical's wireless, handheld TMINI Miniature Robotic System. The exclusive version of the TMINI System is compatible with Zimmer Biomet's Persona Knee System for total knee arthroplasty.</p><p>Think Surgical CEO Stuart Simpson said the extension "confirms the value the TMINI System has been providing to Zimmer Biomet's customers and their patients."</p><p>Brad Kessler, President of Americas Robotics, Technology and http://www.streetinsider.com/Corporate+News/Zimmer+Biomet+and+Think+Surgical+extend+robotic+distribution+deal/27177112.html Tue, 13 Oct 2026 07:32:43 -0400 ZBH http://www.streetinsider.com/Press+Releases/ZIMMER+BIOMET+AND+THINK+SURGICAL+EXTEND+EXCLUSIVE+DISTRIBUTION+AGREEMENT/27177048.html <div class="xn-content"> <p class="prntac"><b><i>Multi-Year Extension to Help Accelerate Adoption of Wireless, Handheld TMINI^® System for Use with <span value="NYSE:ZBH" idsrc="xmltag.org" >Zimmer Biomet's</span> Persona^® Knee System </i></b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.freont" idsrc="xmltag.org" >FREMONT, Calif.</location> and WARSAW, Ind.</span>, <span class="legendSpanClass"><chron>Oct. 13, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:ZBH" idsrc="xmltag.org" >Zimmer Biomet Holdings, Inc.</span> (NYSE and SIX: ZBH), a global medical technology leader, and <span value="ACORN:5021692023" idsrc="xmltag.org" >THINK Surgical, Inc.</span>, an innovator in the field of orthopedic http://www.streetinsider.com/Press+Releases/ZIMMER+BIOMET+AND+THINK+SURGICAL+EXTEND+EXCLUSIVE+DISTRIBUTION+AGREEMENT/27177048.html Tue, 13 Oct 2026 07:30:00 -0400 ZBH http://www.streetinsider.com/PRNewswire/ZIMMER+BIOMET+AND+THINK+SURGICAL+EXTEND+EXCLUSIVE+DISTRIBUTION+AGREEMENT/27177048.html <div class="xn-content"> <p class="prntac"><b><i>Multi-Year Extension to Help Accelerate Adoption of Wireless, Handheld TMINI^® System for Use with <span value="NYSE:ZBH" idsrc="xmltag.org" >Zimmer Biomet's</span> Persona^® Knee System </i></b></p> <p><span class="legendSpanClass"><location value="LU/us.ca.freont" idsrc="xmltag.org" >FREMONT, Calif.</location> and WARSAW, Ind.</span>, <span class="legendSpanClass"><chron>Oct. 13, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:ZBH" idsrc="xmltag.org" >Zimmer Biomet Holdings, Inc.</span> (NYSE and SIX: ZBH), a global medical technology leader, and <span value="ACORN:5021692023" idsrc="xmltag.org" >THINK Surgical, Inc.</span>, an innovator in the field of orthopedic http://www.streetinsider.com/PRNewswire/ZIMMER+BIOMET+AND+THINK+SURGICAL+EXTEND+EXCLUSIVE+DISTRIBUTION+AGREEMENT/27177048.html Tue, 13 Oct 2026 07:30:00 -0400 ZBH http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/New+Coverage/Barclays+Starts+Zimmer+Biomet+%28ZBH%29+at+Equalweight/27155836.html <p>Barclays analyst Matt Miksic initiates coverage on Zimmer Biomet (NYSE: ZBH) with a Equalweight rating and a price target of $100.00.</p> <p>For an analyst ratings summary and ratings history on Zimmer Biomet <a href="http://www.streetinsider.com/rating_history.php?q=ZBH">click here</a>. For more ratings news on Zimmer Biomet <a href="http://www.streetinsider.com/stock_lookup_news.php?q=ZBH&amp;type=analyst">click here</a>.</p> <p>Shares of Zimmer Biomet closed at $91.57 yesterday.</p> http://www.streetinsider.com/New+Coverage/Barclays+Starts+Zimmer+Biomet+%28ZBH%29+at+Equalweight/27155836.html Tue, 06 Oct 2026 16:24:58 -0400 ZBH http://www.streetinsider.com/Press+Releases/Zimmer+Biomet+Announces+Webcast+and+Conference+Call+of+Third+Quarter+2026+Financial+Results/27151864.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.in.warsaw" idsrc="xmltag.org" >WARSAW, Ind.</location></span>, <span class="legendSpanClass"><chron>Oct. 6, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:ZBH" idsrc="xmltag.org" >Zimmer Biomet Holdings, Inc.</span> (NYSE and SIX: ZBH), a global medical technology leader, today announced its third quarter earnings conference call will be webcast on <chron>Wednesday, November 4, 2026</chron>, at <chron>8:30 a.m. ET</chron>. A news release detailing the quarterly results will be made available that day at <chron>6:30 a.m. ET</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Zimmer+Biomet+Announces+Webcast+and+Conference+Call+of+Third+Quarter+2026+Financial+Results/27151864.html Tue, 06 Oct 2026 07:30:00 -0400 ZBH http://www.streetinsider.com/PRNewswire/Zimmer+Biomet+Announces+Webcast+and+Conference+Call+of+Third+Quarter+2026+Financial+Results/27151864.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.in.warsaw" idsrc="xmltag.org" >WARSAW, Ind.</location></span>, <span class="legendSpanClass"><chron>Oct. 6, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:ZBH" idsrc="xmltag.org" >Zimmer Biomet Holdings, Inc.</span> (NYSE and SIX: ZBH), a global medical technology leader, today announced its third quarter earnings conference call will be webcast on <chron>Wednesday, November 4, 2026</chron>, at <chron>8:30 a.m. ET</chron>. A news release detailing the quarterly results will be made available that day at <chron>6:30 a.m. ET</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Zimmer+Biomet+Announces+Webcast+and+Conference+Call+of+Third+Quarter+2026+Financial+Results/27151864.html Tue, 06 Oct 2026 07:30:00 -0400 ZBH http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ZIMMER+BIOMET+HOLDINGS%2C+++For%3A+Oct+01++Filed+by%3A+Campbell+Gary+Craig/27148902.html si-local-file:///var/storage/secattach/20261005/27148902.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ZIMMER+BIOMET+HOLDINGS%2C+++For%3A+Oct+01++Filed+by%3A+Campbell+Gary+Craig/27148902.html Mon, 05 Oct 2026 16:12:00 -0400 ZBH http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ZIMMER+BIOMET+HOLDINGS%2C+++For%3A+Oct+01++Filed+by%3A+Hatcher+Brian+Matthew/27148890.html si-local-file:///var/storage/secattach/20261005/27148890.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ZIMMER+BIOMET+HOLDINGS%2C+++For%3A+Oct+01++Filed+by%3A+Hatcher+Brian+Matthew/27148890.html Mon, 05 Oct 2026 16:11:00 -0400 ZBH http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ZIMMER+BIOMET+HOLDINGS%2C+++For%3A+Oct+01++Filed+by%3A+Campbell+Gary+Craig/27148852.html si-local-file:///var/storage/secattach/20261005/27148852.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ZIMMER+BIOMET+HOLDINGS%2C+++For%3A+Oct+01++Filed+by%3A+Campbell+Gary+Craig/27148852.html Mon, 05 Oct 2026 16:10:00 -0400 ZBH http://www.streetinsider.com/Trader+Talk/Citi+Adjusts+Catalyst+Watch+List/27145352.html <p>Citi Adjusts Catalyst Watch List.</p><ul><li>Sight Sciences (NASDAQ: SGHT) adds to 90-Day upside catalyst watch list.</li><li>Zimmer Biomet Holdings (NYSE: ZBH) adds to 90-Day upside catalyst watch list.</li><li>Edwards Lifesciences (NYSE: EW) adds to 90-Day upside catalyst watch list.</li><li>Boston Scientific (NYSE: BSX) adds to 90-Day upside catalyst watch list.</li></ul> http://www.streetinsider.com/Trader+Talk/Citi+Adjusts+Catalyst+Watch+List/27145352.html Mon, 05 Oct 2026 06:57:43 -0400 BSX EW SGHT ZBH http://www.streetinsider.com/Trader+Talk/Citi+Adjusts+Catalyst+Watch+List/27145352.html <p>Citi Adjusts Catalyst Watch List.</p><ul><li>Sight Sciences (NASDAQ: SGHT) adds to 90-Day upside catalyst watch list.</li><li>Zimmer Biomet Holdings (NYSE: ZBH) adds to 90-Day upside catalyst watch list.</li><li>Edwards Lifesciences (NYSE: EW) adds to 90-Day upside catalyst watch list.</li><li>Boston Scientific (NYSE: BSX) adds to 90-Day upside catalyst watch list.</li></ul> http://www.streetinsider.com/Trader+Talk/Citi+Adjusts+Catalyst+Watch+List/27145352.html Mon, 05 Oct 2026 06:57:43 -0400 BSX EW SGHT ZBH